Veramed Acquires Clinical Trial Data Services (CTDS)
October 9, 2023
Veramed, a specialist biometrics CRO, has acquired Clinical Trial Data Services (CTDS), a data management, biostatistics and medical writing firm founded by Terri Sampo. The acquisition expands Veramed's global footprint and data management capabilities, growing the combined biometrics team to over 350 professionals and enhancing end-to-end biometrics support for biotech and pharma sponsors.
- Buyers
- Veramed
- Targets
- Clinical Trial Data Services (CTDS)
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Veristat Acquires The Clinical Trial Company Ltd (TCTC Group)
January 6, 2020
Healthcare Services
Veristat, a full-service CRO based in Southborough, Massachusetts, has acquired The Clinical Trial Company Ltd (TCTC Group), a Europe-headquartered contract research organization. The deal expands Veristat's European footprint and adds TCTC's expertise in gene and cell therapy, CNS and orphan disease clinical trials to Veristat's service offering.
-
Livingbridge Invests in Veramed
November 5, 2021
Healthcare Services
Livingbridge has made a minority growth investment in Veramed, a London-headquartered biometrics Contract Research Organization (CRO) that provides biostatistics, programming and study reporting services to pharmaceutical and biotech clients. The founders, Matthew and Emma Jones, will retain a significant shareholding and management will remain in place; Livingbridge's Enterprise 3 fund will support Veramed's geographic expansion and capability broadening.
-
BioIVT Acquires PrecisionMed
July 18, 2023
Healthcare Services
BioIVT, a global biospecimen solutions provider, has acquired PrecisionMed, LLC, a Carlsbad-based supplier of high-quality human biospecimens and owner of a large longitudinal cerebrospinal fluid (CSF) repository. The acquisition expands BioIVT's supply network, inventory and capacity for CSF and liquid biopsy products while PrecisionMed will continue to operate from its existing headquarters and collection sites.
-
Velocity Clinical Research Acquires Meridian Clinical Research
December 15, 2022
Healthcare Services
Velocity Clinical Research, a GHO-backed integrated research site organization, has acquired Meridian Clinical Research for an undisclosed amount. The deal creates the largest dedicated clinical research site organization globally (about 80 sites), expands Velocity's U.S. footprint to 25 states and adds Meridian's network of 35+ sites and experienced investigators and staff.
-
CenExel Clinical Research Acquires CTSdatabase
February 22, 2022
Healthcare Services
CenExel Clinical Research has acquired CTSdatabase, a global duplicate-subject detection and clinical trial registry led by Dr. Thomas M. Shiovitz. The acquisition integrates CTSdatabase's subject-detection capabilities into CenExel's site network to improve data quality across clinical trials while CTSdatabase will continue to operate independently and support external sponsors and CROs.
-
Ergomed plc Acquires MS Clinical Services (MedSource)
December 14, 2020
Healthcare Services
Ergomed plc has acquired MS Clinical Services, LLC (MedSource), a Houston-based full-service CRO specializing in oncology and rare disease, for an initial $16.2 million in cash plus potential shares and contingent consideration. The acquisition expands Ergomed's US footprint (adding ~110 US employees and offices in Houston, Raleigh and Boston), strengthens its specialist clinical research capabilities and is expected to be immediately accretive.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.